232 related articles for article (PubMed ID: 3116598)
1. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
Martin DF; Porter EA; Fischer JJ; Rockwell S
Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598
[TBL] [Abstract][Full Text] [Related]
2. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
Morton JD; Porter E; Yabuki H; Nath R; Rockwell S
Radiat Res; 1990 Nov; 124(2):178-82. PubMed ID: 2123353
[TBL] [Abstract][Full Text] [Related]
3. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
Lee I; Levitt SH; Song CW
Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
[TBL] [Abstract][Full Text] [Related]
4. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
[TBL] [Abstract][Full Text] [Related]
5. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
Moulder JE; Fish BL
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitization of murine tumors by Fluosol-DA 20%.
Lee I; Levitt SH; Song CW
Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
[TBL] [Abstract][Full Text] [Related]
7. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
Teicher BA; Holden SA; Jacobs JL
Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
[TBL] [Abstract][Full Text] [Related]
8. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
Rockwell S; Mate TP; Irvin CG; Nierenburg M
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
Teicher BA; Holden SA; Northey D; Dewhirst MW; Herman TS
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):103-9. PubMed ID: 8482616
[TBL] [Abstract][Full Text] [Related]
10. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
Holden SA; Teicher BA; McIntosh NL; Rose CM
Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
[TBL] [Abstract][Full Text] [Related]
11. [Minimal effective dose of perfluorochemical emulsion as a radiosensitizer].
Hishikawa-Itoh Y; Kato T; Niwa T; Ayakawa Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1243-8. PubMed ID: 2794648
[TBL] [Abstract][Full Text] [Related]
12. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
Teicher BA; Herman TS; Rose CM
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
[TBL] [Abstract][Full Text] [Related]
13. Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy.
Rockwell S; Irvin CG; Kelley M
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):913-20. PubMed ID: 3141320
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of rat brain tumor therapy by fluosol and carbogen.
Martin DF; Kimler BF; Evans RG; Morantz RA; Vats TS
NCI Monogr; 1988; (6):119-22. PubMed ID: 3127732
[TBL] [Abstract][Full Text] [Related]
15. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
[TBL] [Abstract][Full Text] [Related]
16. MRI measurements correctly predict the relative effects of tumor oxygenating agents on hypoxic fraction in rodent BA1112 tumors.
Al-Hallaq HA; Zamora M; Fish BL; Farrell A; Moulder JE; Karczmar GS
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):481-8. PubMed ID: 10802376
[TBL] [Abstract][Full Text] [Related]
17. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
el-Said A; Menke D; Dorie MJ; Brown JM
Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of tumor radiation response by the combination of a perfluorochemical emulsion and hyperbaric oxygen.
Martin DF; Porter EA; Rockwell S; Fischer JJ
Int J Radiat Oncol Biol Phys; 1987 May; 13(5):747-51. PubMed ID: 3570898
[TBL] [Abstract][Full Text] [Related]
20. Optimization of perfluorochemical levels with radiation therapy in mice.
Teicher BA; Herman TS; Jones SM
Cancer Res; 1989 May; 49(10):2693-7. PubMed ID: 2713854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
